GB201106548D0 - A method for determining ligand binding to a target protein using a thermal shift assahy - Google Patents

A method for determining ligand binding to a target protein using a thermal shift assahy

Info

Publication number
GB201106548D0
GB201106548D0 GBGB1106548.9A GB201106548A GB201106548D0 GB 201106548 D0 GB201106548 D0 GB 201106548D0 GB 201106548 A GB201106548 A GB 201106548A GB 201106548 D0 GB201106548 D0 GB 201106548D0
Authority
GB
United Kingdom
Prior art keywords
target protein
protein
assahy
ligand binding
thermal shift
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1106548.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evitraproteoma AB
Original Assignee
Evitraproteoma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evitraproteoma AB filed Critical Evitraproteoma AB
Priority to GBGB1106548.9A priority Critical patent/GB201106548D0/en
Publication of GB201106548D0 publication Critical patent/GB201106548D0/en
Priority to GB1206834.2A priority patent/GB2490404B/en
Priority to PCT/GB2012/050853 priority patent/WO2012143714A1/en
Priority to ES12717826.7T priority patent/ES2566637T3/es
Priority to AU2012246069A priority patent/AU2012246069B2/en
Priority to SG2013075072A priority patent/SG194137A1/en
Priority to EP12717826.7A priority patent/EP2699910B1/en
Priority to CN201280025677.XA priority patent/CN103733067B/zh
Priority to KR1020137030379A priority patent/KR101940342B1/ko
Priority to CA2833076A priority patent/CA2833076C/en
Priority to HK14104821.1A priority patent/HK1192612B/en
Priority to DK12717826.7T priority patent/DK2699910T3/en
Priority to MYPI2013003781A priority patent/MY171913A/en
Priority to JP2014505717A priority patent/JP6032715B2/ja
Priority to US14/057,920 priority patent/US8969014B2/en
Priority to US14/599,256 priority patent/US9523693B2/en
Priority to US14/602,993 priority patent/US9528996B2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/32—Extraction; Separation; Purification by precipitation as complexes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446—Antibacterials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9453—Cardioregulators, e.g. antihypotensives, antiarrhythmics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9466—Antidepressants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9473—Anticonvulsants, e.g. phenobarbitol, phenytoin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9493—Immunosupressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GBGB1106548.9A 2011-04-18 2011-04-18 A method for determining ligand binding to a target protein using a thermal shift assahy Ceased GB201106548D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB1106548.9A GB201106548D0 (en) 2011-04-18 2011-04-18 A method for determining ligand binding to a target protein using a thermal shift assahy
JP2014505717A JP6032715B2 (ja) 2011-04-18 2012-04-18 サーマルシフトアッセイを使用した、標的タンパク質とのリガンド結合を決定するための方法
KR1020137030379A KR101940342B1 (ko) 2011-04-18 2012-04-18 열적 변화 분석법을 이용한 표적 단백질에 결합하는 리간드를 결정하는 방법
HK14104821.1A HK1192612B (en) 2011-04-18 2012-04-18 Methods for determining ligand binding to a target protein using a thermal shift assay
ES12717826.7T ES2566637T3 (es) 2011-04-18 2012-04-18 Métodos para determinar la unión de un ligando a una proteína diana utilizando un ensayo de cambio térmico
AU2012246069A AU2012246069B2 (en) 2011-04-18 2012-04-18 Methods for determining ligand binding to a target protein using a thermal shift assay
SG2013075072A SG194137A1 (en) 2011-04-18 2012-04-18 Methods for determining ligand binding to a target protein using a thermal shift assay
EP12717826.7A EP2699910B1 (en) 2011-04-18 2012-04-18 Methods for determining ligand binding to a target protein using a thermal shift assay
CN201280025677.XA CN103733067B (zh) 2011-04-18 2012-04-18 使用热转移试验测定配体与靶蛋白结合的方法
GB1206834.2A GB2490404B (en) 2011-04-18 2012-04-18 Methods for determining ligand binding to a target protein using a thermal shift assay
CA2833076A CA2833076C (en) 2011-04-18 2012-04-18 Methods for determining ligand binding to a target protein using a thermal shift assay
PCT/GB2012/050853 WO2012143714A1 (en) 2011-04-18 2012-04-18 Methods for determining ligand binding to a target protein using a thermal shift assay
DK12717826.7T DK2699910T3 (en) 2011-04-18 2012-04-18 A method for determining ligand binding to a target protein using a thermal shift assay
MYPI2013003781A MY171913A (en) 2011-04-18 2012-04-18 Methods for determining ligand binding to a target protein using a thermal shift assay
US14/057,920 US8969014B2 (en) 2011-04-18 2013-10-18 Methods for determining ligand binding to a target protein using a thermal shift assay
US14/599,256 US9523693B2 (en) 2011-04-18 2015-01-16 Methods for determining ligand binding to a target protein using a thermal shift assay
US14/602,993 US9528996B2 (en) 2011-04-18 2015-01-22 Methods for determining ligand binding to a target protein using a thermal shift assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1106548.9A GB201106548D0 (en) 2011-04-18 2011-04-18 A method for determining ligand binding to a target protein using a thermal shift assahy

Publications (1)

Publication Number Publication Date
GB201106548D0 true GB201106548D0 (en) 2011-06-01

Family

ID=44147179

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1106548.9A Ceased GB201106548D0 (en) 2011-04-18 2011-04-18 A method for determining ligand binding to a target protein using a thermal shift assahy
GB1206834.2A Active GB2490404B (en) 2011-04-18 2012-04-18 Methods for determining ligand binding to a target protein using a thermal shift assay

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1206834.2A Active GB2490404B (en) 2011-04-18 2012-04-18 Methods for determining ligand binding to a target protein using a thermal shift assay

Country Status (13)

Country Link
US (2) US8969014B2 (enExample)
EP (1) EP2699910B1 (enExample)
JP (1) JP6032715B2 (enExample)
KR (1) KR101940342B1 (enExample)
CN (1) CN103733067B (enExample)
AU (1) AU2012246069B2 (enExample)
CA (1) CA2833076C (enExample)
DK (1) DK2699910T3 (enExample)
ES (1) ES2566637T3 (enExample)
GB (2) GB201106548D0 (enExample)
MY (1) MY171913A (enExample)
SG (1) SG194137A1 (enExample)
WO (1) WO2012143714A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9523693B2 (en) 2011-04-18 2016-12-20 Biotarget Engagement Interest Group Ab Methods for determining ligand binding to a target protein using a thermal shift assay
GB201106548D0 (en) 2011-04-18 2011-06-01 Evitraproteoma Ab A method for determining ligand binding to a target protein using a thermal shift assahy
CN103645324B (zh) * 2013-12-03 2017-02-15 胡朝阳 基于细胞热转移技术的高通量药物靶点筛选方法
GB2524519B (en) 2014-03-25 2019-11-06 Pelago Bioscience AB Methods for identifying a biomarker indicative of a reduced drug response using a thermal shift assay
WO2016028804A1 (en) * 2014-08-21 2016-02-25 Discoverx Corporation Homogenous thermal shift ligand binding assay
WO2016127100A1 (en) 2015-02-05 2016-08-11 Promega Corporation Luciferase-based thermal shift assays
US11024492B2 (en) 2015-07-07 2021-06-01 Institute For Systems Biology Method to obtain unbiased identification of interaction of test compounds with the proteome
CN105424928B (zh) * 2015-11-11 2017-05-17 山西隆克尔生物制药有限公司 一种检测猪繁殖与呼吸综合征病毒抗体的免疫层析条及其制备方法和应用
WO2017206041A1 (zh) * 2016-05-31 2017-12-07 王帅 测定细胞内配体靶蛋白相互作用持久力的方法
US11567074B2 (en) * 2016-09-26 2023-01-31 University of Pittsburgh—of the Commonwealth System of Higher Education Methods for identifying proteins that bind ligands
KR101862198B1 (ko) * 2016-09-30 2018-05-30 (주)스파크바이오파마 2차원 겔 전기영동에서의 열 안정성 변화-기반 형광 차이를 이용한 표적 단백질의 규명 방법
US11630110B2 (en) 2017-08-18 2023-04-18 Agency For Science, Technology And Research Methods to identify protein interaction
EP3575416A1 (en) * 2018-06-01 2019-12-04 InfanDx AG Detection of target molecules by determining the melting temperature of a recognition module
GB201814451D0 (en) * 2018-09-05 2018-10-17 Valerie Nicholas Carl Kristoffer Methods
CN112924693B (zh) * 2019-12-06 2022-09-27 中国科学院大连化学物理研究所 一种上清和沉淀协同定量的蛋白质热稳定性分析方法
CN112924694A (zh) * 2019-12-06 2021-06-08 中国科学院大连化学物理研究所 一种无歧视的蛋白质热稳定性分析方法
JP7502861B2 (ja) * 2019-12-27 2024-06-19 旭化成株式会社 標的物質と両親媒性高分子との複合体の形成反応の反応温度の評価方法
CN111551749A (zh) * 2020-06-12 2020-08-18 郑州大学 一种鉴定药物靶蛋白的方法
CN114076826A (zh) * 2020-08-20 2022-02-22 中国科学院大连化学物理研究所 一种微球辅助的基于蛋白加热沉淀的药物靶蛋白筛选方法
EP4378586A1 (en) 2022-12-01 2024-06-05 Bayer AG Integrated system for chemical, biochemical, or biological reactions in a microplate submitted to a temperature gradient
WO2024261269A1 (en) 2023-06-22 2024-12-26 Omicscouts Gmbh Method for detecting ligand-target interactions using solvent- induced precipitation in intact cells
CN116577472B (zh) * 2023-07-12 2023-10-31 中国中医科学院中药研究所 植物细胞环境蛋白组学分析方法及应用
GB2634749A (en) * 2023-10-18 2025-04-23 Proteinera Holding Ab Methods for detecting apoptosis
GB2634751A (en) * 2023-10-18 2025-04-23 Proteinera Holding Ab Methods for detecting protein cleavage
WO2025247735A1 (en) 2024-05-29 2025-12-04 Bayer Aktiengesellschaft Solvent induced precipitation (sip) assays using specific solvent combinations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780409A (en) 1985-05-02 1988-10-25 Genetic Systems Corporation Thermally induced phase separation immunoassay
US6020141A (en) * 1996-05-09 2000-02-01 3-Dimensional Pharmaceuticals, Inc. Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization
WO1999024050A1 (en) * 1997-11-12 1999-05-20 3-Dimensional Pharmaceuticals, Inc. High throughput method for functionally classifying proteins identified using a genomics approach
US6171850B1 (en) 1999-03-08 2001-01-09 Caliper Technologies Corp. Integrated devices and systems for performing temperature controlled reactions and analyses
US6376180B1 (en) * 1999-12-09 2002-04-23 Pharmacia & Upjohn Company Methods of identifying compounds that bind to target species under isothermal denaturing conditions
JP2004537047A (ja) * 2001-06-14 2004-12-09 アナディーズ　ファーマスーティカルズ，アイエヌシー． 標的分子のリガンドをスクリーニングする方法
EP2357237A1 (en) * 2003-05-14 2011-08-17 Domantis Limited A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
GB0315525D0 (en) 2003-07-02 2003-08-06 Nordlund Paer A method of screening
JP4695851B2 (ja) 2003-07-10 2011-06-08 シチズンホールディングス株式会社 マイクロ化学チップ温度調節装置
JP5502275B2 (ja) 2004-05-02 2014-05-28 フルイディグム コーポレイション 熱反応デバイスおよびその熱反応デバイスの使用方法
WO2006110292A2 (en) * 2005-03-25 2006-10-19 The Regents Of The University Of California Temperature-triggered immobilization and purification of antibodies
LT5504B (lt) * 2006-08-02 2008-06-25 Biotechnologijos Institutas Benzimidazo[1,2-c][1,2,3]tiadiazolo sulfonamidai - karboanhidrazių slopikliai ir tarpiniai junginiai jiems gauti
US20100256342A1 (en) * 2008-08-12 2010-10-07 Francis Raymond Salemme Protein nodes for controlled nanoscale assembly
JP2012531582A (ja) * 2009-06-26 2012-12-10 アトラス・アンティボディーズ・アクチボラゲット 免疫検出性の改善
US8476081B2 (en) * 2009-09-21 2013-07-02 Janssen Pharmaceutica Nv Assay for evaluating affinity and specificity of ligand-albumin binding
US9523693B2 (en) 2011-04-18 2016-12-20 Biotarget Engagement Interest Group Ab Methods for determining ligand binding to a target protein using a thermal shift assay
GB201106548D0 (en) 2011-04-18 2011-06-01 Evitraproteoma Ab A method for determining ligand binding to a target protein using a thermal shift assahy

Also Published As

Publication number Publication date
SG194137A1 (en) 2013-11-29
ES2566637T3 (es) 2016-04-14
DK2699910T3 (en) 2016-04-18
AU2012246069B2 (en) 2016-09-22
CN103733067A (zh) 2014-04-16
HK1192612A1 (zh) 2014-08-22
CA2833076A1 (en) 2012-10-26
GB2490404B (en) 2013-11-06
AU2012246069A1 (en) 2013-10-31
GB2490404A (en) 2012-10-31
JP2014513293A (ja) 2014-05-29
GB201206834D0 (en) 2012-05-30
US9528996B2 (en) 2016-12-27
KR20140033366A (ko) 2014-03-18
CN103733067B (zh) 2016-01-13
EP2699910A1 (en) 2014-02-26
KR101940342B1 (ko) 2019-01-18
MY171913A (en) 2019-11-06
JP6032715B2 (ja) 2016-11-30
US20140057368A1 (en) 2014-02-27
EP2699910B1 (en) 2016-03-09
WO2012143714A1 (en) 2012-10-26
CA2833076C (en) 2020-07-14
US8969014B2 (en) 2015-03-03
US20150140575A1 (en) 2015-05-21

Similar Documents

Publication Publication Date Title
GB2490404B (en) Methods for determining ligand binding to a target protein using a thermal shift assay
JO3812B1 (ar) أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1)
BR112016004437A2 (pt) métodos de imunoteste e de seleção de linhagem de células, anticorpos e kit
EP4010456A4 (en) Systems and methods for sample preparation, data generation, and protein corona analysis
PH12013501177A1 (en) TNF-a BINDING PROTEINS
MX347818B (es) Dominios que enlazan suero desinmunizados y su uso para prolongar la vida media en suero.
PH12015502849A1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
BR112017006598A2 (pt) anticorpo de repetições antidipeptídeo derivado de ser humano (dprs)
MX2017011489A (es) Detección de moléculas pequeñas mediante nanoporos a través de ensayos de competición.
WO2019060750A3 (en) A33 antibody compositions and methods of using the same in radioimmunotherapy
TW201233686A (en) Monoclonal antibody recognizing human papillomavirus (HPV) L2 protein and method for measuring HPV-neutralizing antibody titer using the same
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
WO2015006337A3 (en) Compositions and methods for increasing protein half-life in a serum
MX353464B (es) Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles.
WO2010009856A3 (en) Goodpasture antigen binding protein and its detection
WO2011037827A3 (en) Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
WO2006034278A3 (en) Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
WO2011109112A3 (en) Method of detecting tau protein and tau fragments in serum
EA201692071A1 (ru) Иммуноанализ и антитела для обнаружения хромогранина а
MX374731B (es) Método para la detección de un anticuerpo igm específico para un flavivirus en una muestra.
PL1991875T3 (pl) Test do wykrywania patologicznych prionów
WO2015193552A3 (en) Means and methods for determining risk of type-1 diabetes by serum protein biomarkers
EA201490286A1 (ru) Моноклональные антитела, специфичные в отношении x-37 бета-амилоида, и пути их применения
WO2013003691A3 (en) Methods for diagnosing and monitoring diseases or conditions using disease modified biomolecules and measurement of a functional immune response
WO2014151021A3 (en) Antibody profiling, methods and apparatus for identifying an individual or source of a biological material

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)